This was intended to be a "good news/bad news" report on the current state of biotechnology hiring. As it turns out, the bad news is that I can't find anything for the "good" piece of that equation. With the war adding to the general insecurity that many feel, the job market isn't a real pleasure to be a part of right now. As a biotechnology headhunter, I've staffed young companies and helped them manage the development of new medicines. Now these same firms are in need of a fix themselves, a

I enjoyed "Outlook 2002: Jobs abundant despite recession,"1 because it provided an interesting historical perspective to the current biotech job market. However, I believe that it is dangerous to start making the job market look so hot that just about anyone can fall into a good, high-paying job right out of a grad program or postdoc. I don't think that this helps anyone who is job seeking--it only creates frustration and a feeling of abandonment. Many articles in the non-science media have pr

Thank you for your increasing coverage of professional and career-related material of interest to scientists. I've noticed the trend, and it is certainly a positive one for The Scientist. However, I must take exception to the cover story by Franklin Hoke in the March 20, 1995, issue. This feature, entitled "Smaller Biotechs Capturing Top Talent From Large Pharmaceutical Competitors" [page 1], seems to perpetuate a number of stereotypes that could have been presented in a more balanced fashion.